Investor
Vantage Consulting Group Inc
CIK 0001843547 · filed 2026-02-11 · SEC filing
13F book
$19.7M
Positions
3
Largest name
77.7%
Babcock & Wilcox Enterprises
Est. mark
—
Need a prior quarter to estimate
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Babcock & Wilcox Enterprises | — | 2.42M | $15.3M | 77.7% | — | Held |
| Adc Therapeutics Sa | ADCT | 683K | $2.41M | 12.2% | — | Held |
| Cibus, Inc. | CBUS | 1.14M | $1.99M | 10.1% | — | Held |
Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.